Status:
RECRUITING
Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
AISDTS is a prospective registry study, in which clinical information, examination and imaging data of patients with acute ischemic stroke receiving different treatment strategies were collected, grou...
Detailed Description
1. To study which variable or variables (various clinical biological indicators) affect the prognosis of ischemic stroke patients; 2. To study the differences in variables (various clinical evaluation...
Eligibility Criteria
Inclusion
- A) ≥18 years of age; B) hospital admission for ischemic stroke; C) Signed informed consent.
Exclusion
- A) patients with incomplete clinical information; B) hospitalization observation time less than 24 hours; C) recent trauma, severe inflammation, severe liver and kidney dysfunction, progressive malignance and other serious diseases; D) baseline mRS score\>2; E) informed consent is not signed.
Key Trial Info
Start Date :
May 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 24 2027
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05410457
Start Date
May 24 2022
End Date
June 24 2027
Last Update
November 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, China, 210006